CLYM Climb Bio Inc: Rentabilitas operasi

Logo perusahaan publik Climb Bio, Inc (CLYM)

Climb Bio Inc (CLYM) minimizes investment risks by diversifying its immune pathology therapy programs. The change in operating margin on the GURU.Markets terminal line chart is recorded at 0.00. While clinical test efficiency relies on rigorous pharmaceutical logistics, the lack of profitable products leaves the company dependent on external capital injections due to negative cash flow.

CLYM: Rentabilitas operasi Climb Bio Inc. 04.10.2024 - 19.11.2026

Rincian metrik komprehensif lan analitis Climb Bio Inc (CLYM)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:CLYM, climbbio.com
Produk dadi Climb Bio, Inc

Climb Bio Inc (CLYM) focuses on developing targeted therapies to combat autoimmune pathologies. This metric is calculated as the ratio of operating profit to revenue, determining cost management efficiency before accounting for financial expenses. The investor separates fundamental stability from market noise, assessing the business's ability to generate cash flow. By analyzing operating profitability via EBIT, one can identify the biotech's transition stage from costs to profit.

Pesaing Climb Bio Inc

ARGX (argenx N.V.) - Margin operasi|Rentabilitas dodolan operasi BioNTech Pharma BNTX|Margin dodolan operasi ABVX (ABIVAX)|Margin operasi ADMA Biologics, Inc. (ADMA)|Margin operasi PTGX (protagonist-inc.com)|IMVT: Rentabilitas dodolan miturut bathi operasi|KNSA - Rentabilitas operasi|GRFS: Rentabilitas operasi|ADPT (Adaptive Biotechnologies) - Margin dodolan operasi|Rentabilitas dodolan miturut bathi operasi CLDX|Margin dodolan operasi AUPH|BCRX (BioCryst Pharmaceuticals) - Rasio bathi operasi|Rentabilitas operasi Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Tingkat bathi operasi|Pharvaris N.V. - Margin dodolan operasi|Tingkat bathi operasi ABCL|TRML: Margin dodolan operasi|PGEN (Precigen) - Rentabilitas dodolan miturut bathi operasi|pharming.com (PHAR) - Rentabilitas operasi|Nektar Corp (NKTR) - Margin operasi|UPB (upstreambio.com) - Margin operasi|ZBIO: Tingkat bathi operasi|Margin operasi IMNM|Rentabilitas kegiatan operasi Gossamer Bio Inc|Margin operasi KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Margin bathi operasi|PVLA: Margin dodolan operasi|Margin bathi operasi SVRA|RIGL: Margin operasi|Rentabilitas dodolan miturut bathi operasi ANAB|ATXS (Astria Corp) - Margin operasi|Rentabilitas dodolan miturut bathi operasi ENGN (enGene Bio)|Margin operasi RAPT|Rentabilitas kegiatan operasi Aerovate Therapeutics|Rentabilitas operasi Aclaris Therapeutics Inc. ACRS|Rentabilitas kegiatan operasi Kyverna Therapeutics Inc. (KYTX)|TLSA - Rentabilitas operasi|CABA: Rentabilitas operasi|VTYX (Ventyx Biosciences, Inc.) - Margin dodolan operasi|THTX - Rentabilitas kegiatan operasi|AVTX (avalotx.com) - Margin operasi|Rentabilitas dodolan operasi Eledon Pharmaceuticals Inc. ELDN|Margin operasi AGEN|ZURA (Zura Bio Ltd) - Tingkat bathi operasi|Rentabilitas operasi atyrpharma.com ATYR|Margin operasi Adagene Corp ADAG|IMA - Rentabilitas operasi|Tingkat bathi operasi STTK (Shattuck Labs)|EQ: Margin operasi|Connect Biopharma (CNTB) - Margin operasi|Rentabilitas operasi Immunic|Margin operasi atarabio.com|Margin operasi IFRX|Margin operasi X4 Pharma (XFOR)|Margin operasi ACET (adicetbio.com)|Margin operasi Celularity Inc. CELU|INMB - Rentabilitas operasi|Tingkat bathi operasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Margin dodolan operasi|Margin dodolan operasi SAB Biotherapeutics Inc.|Margin dodolan operasi AKTX|Margin dodolan operasi enlivex.com (ENLV)|Rentabilitas operasi Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Tingkat bathi adhedhasar bathi operasi|Margin operasi EDSA (Edesa Biotech Corp)|Rentabilitas kegiatan operasi iBio (IBIO)|CARM - Rentabilitas operasi|XTL Biopharmaceuticals (XTLB) - Margin dodolan operasi|BOLT: Margin operasi|Margin dodolan operasi HCW Biologics Inc.|Rentabilitas operasi Aptevo|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com